Hoffman R, Lethen H, Kleinhans E, Kruger S, Flachskampf F A, Hanrath P
Medizinische Klinik I, Klinikum RWTH Aachen.
Z Kardiol. 1996 Jan;85(1):20-7.
Dobutamine stress echocardiography has proven to be a method with high diagnostic accuracy in the detection of coronary artery disease. In case of previous myocardial infarction it is of importance to detect additional regions with inducible myocardial ischemia. This study aimed at the detection of inducible ischemia by dobutamine stress echocardiography and stress perfusion scintigraphy in patients without and with previous myocardial infarction. 50 patients without as well as 50 patients with previous transmural myocardial infarction were investigated. In all patients coronary angiography, technetium-99m methoxy-isobutyl-isonitrile (MIBI)-SPECT after bicycle ergometry and dobutamine stress echocardiography (up to 40 mcg/kg/min dobutamine, 1 mg atropine) were performed within 14 days. In patients with previous myocardial infarction dobutamine stress echocardiography and MIBI-SPECT had similar sensitivities (91 vs. 94%, n.s.) and specificities (81 vs. 75%; n.s.) in the detection of significant coronary artery disease. Agreement on the presence or absence of inducible ischemia was 84% (Kappa = 0.60). In patients with previous transmural myocardial infarction sensitivity of stress echocardiography and perfusion scintigraphy in the detection of significant coronary artery disease is lower with 63% and 77%, respectively. In this patient group transient perfusion defects were found more frequently than inducible wall motion abnormalities, 76% and 60%, respectively. There was a lower agreement (76%; Kappa = 0.49) in the detection of abnormal or normal results between dobutamine echocardiography and stress perfusion scintigraphy for this group of patients.
This study demonstrates high agreement of dobutamine stress echocardiography and stress perfusion scintigraphy in the evaluation of inducible ischemia in patients without previous transmural myocardial infarction and equal diagnostic accuracy in the detection of coronary artery disease. In patients with previous myocardial infarction there is a lower agreement in the interpretation of patients as having ischemia due to negative dobutamine echo results in patients having positive perfusion scintigraphies.
多巴酚丁胺负荷超声心动图已被证明是一种检测冠状动脉疾病诊断准确性高的方法。对于既往有心肌梗死的患者,检测额外的可诱导性心肌缺血区域很重要。本研究旨在通过多巴酚丁胺负荷超声心动图和负荷灌注闪烁扫描检测无既往心肌梗死和有既往心肌梗死患者的可诱导性缺血。对50例无既往心肌梗死患者以及50例有既往透壁心肌梗死患者进行了研究。所有患者在14天内均接受了冠状动脉造影、运动平板试验后锝-99m甲氧基异丁基异腈(MIBI)单光子发射计算机断层扫描(SPECT)以及多巴酚丁胺负荷超声心动图(多巴酚丁胺剂量高达40 mcg/kg/min,阿托品1 mg)检查。在有既往心肌梗死的患者中,多巴酚丁胺负荷超声心动图和MIBI-SPECT在检测显著冠状动脉疾病方面具有相似的敏感性(分别为91%和94%,无显著差异)和特异性(分别为81%和75%;无显著差异)。关于是否存在可诱导性缺血的一致性为84%(Kappa值 = 0.60)。在有既往透壁心肌梗死的患者中,负荷超声心动图和灌注闪烁扫描检测显著冠状动脉疾病的敏感性较低,分别为63%和77%。在该患者组中,短暂灌注缺损比可诱导性室壁运动异常更常见,分别为76%和60%。对于该组患者,多巴酚丁胺超声心动图和负荷灌注闪烁扫描在检测结果异常或正常方面的一致性较低(76%;Kappa值 = 0.49)。
本研究表明,多巴酚丁胺负荷超声心动图和负荷灌注闪烁扫描在评估无既往透壁心肌梗死患者的可诱导性缺血方面具有高度一致性,在检测冠状动脉疾病方面诊断准确性相当。在有既往心肌梗死的患者中,由于多巴酚丁胺超声心动图结果为阴性而灌注闪烁扫描结果为阳性的患者被判定为有缺血的解读一致性较低。